Based on their similar background of SMARCB1 loss, as has already been stated, RMCs and rhabdoid tumors of the kidney (RTK) share a similar gene expression signature, which is distinct from other renal tumors [10]. This evidence concerns the gene SMARCB1 and rhabdoid tumor of the kidney.